Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Summary

This phase I trial studies the side effects and best dose of vaccine therapy in treating patients with stage III-IV melanoma that has spread to other places in the body and usually cannot be cured or controlled with treatment (advanced). Vaccines made from peptides or antigens may help the body build an effective immune response to kill tumor cells.

Timeline

Start

2013-03-26

Primary completion

2018-06-11

Completion

2018-06-11

Outcome

Outcome not reported

Stopped: “Study was Suspended since 2018; PI decided to terminate.”

Drugs

Indications